Bellicum Pharmaceuticals Inc (STU:BPXA)
€ 0.0635 0 (0%) Market Cap: 617,000.00 Enterprise Value: -4.92 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q3 2019 Bellicum Pharmaceuticals Inc Earnings Call Transcript

Nov 06, 2019 / 10:00PM GMT
Release Date Price: €11.9 (+12.26%)
Operator

Greetings and welcome to the Bellicum Pharmaceuticals Third Quarter 2019 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Mr. Robert Uhl, Westwicke IR. Please go ahead, sir.

Robert H. Uhl
Westwicke Partners, LLC - MD

Thank you, Jerry. Good afternoon, everyone, and thank you for joining us. With me today on the call is Rick Fair, Bellicum's President and Chief Executive Officer; and Atabak Mokari, Chief Financial Officer.

Later, during the Q&A session, Aaron Foster, Head of Research, will also be available. Earlier this afternoon, Bellicum released financial results for the third quarter ended September 30, 2019. If you have not received this release or if you would like to be added to the distribution list, you can do so on the Investor Relations page of the company's website. As a reminder, today's conference call will include forward-looking statements made under the Private Securities Litigation Reform Act of 1995,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot